Latest Period
Q2 2026
Security Snapshot
KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB) Institutional Ownership
CUSIP: 31572Q881
13F Institutional Holders and Ownership History from Q2 2025 to Q2 2026
Institutions Reporting
26
Shares (Excl. Options)
998,983
Price
$7.55
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 par value
- Symbol
- KYNB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 998,983
- Total 13F value
- $7,540,716
- Portfolio coverage rank
- 0%
- Share change
- -35,715
- Value change
- -$251,686
- Number of holders
- 26
- Shares outstanding
- 4,048,583
- SEC-reported price per share
- $7.35
- Insider filing price
- $7.35
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KYNB - KYNTRA BIO, INC. - Common Stock, $0.01 par value is tracked under CUSIP 31572Q881.
- 26 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 31 to 26 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $7,013,757 to $7,540,716.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q2 2026.
Security key
31572Q881
Latest holder period
Q2 2026
13F holders
26
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
KYNB full holder history
KYNTRA BIO, INC. SEC filings
KYNTRA BIO, INC. company facts
KYNTRA BIO, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 31572Q881:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
KYNB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | -0.1% | $2,940,000 | 400,000 | 0% | Armistice Capital, LLC | 30 Jun 2026 | |
| VANGUARD GROUP INC | 4.4% | $916,888 | 178,040 | The Vanguard Group | 30 Jun 2025 |
As of 30 Jun 2026, 26 institutional investors reported holding 998,983 shares of KYNTRA BIO, INC. - Common Stock, $0.01 par value (KYNB). This represents 25% of the company’s total 4,048,583 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
25%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | 400,000 | 0% | 0.08% | $3,020,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 159,950 | +2.1% | 0% | $1,207,623 |
| ACADIAN ASSET MANAGEMENT LLC | 2.6% | 105,585 | 0% | 0% | $795,000 |
| BlackRock, Inc. | 2.1% | 84,330 | -0% | 0% | $636,692 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 43,219 | -6% | 0% | $326,385 |
| HighTower Advisors, LLC | 0.98% | 39,746 | +0.01% | 0% | $300,082 |
| TWO SIGMA INVESTMENTS, LP | 0.98% | 39,511 | -20% | 0% | $298,308 |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 27,081 | -1.5% | 0% | $204,462 |
| VANGUARD FIDUCIARY TRUST CO | 0.6% | 24,105 | +0.68% | 0% | $181,993 |
| Birchview Capital, LP | 0.56% | 22,566 | 0% | 0.08% | $170,373 |
| STATE STREET CORP | 0.5% | 20,284 | 0% | 0% | $153,144 |
| GSA CAPITAL PARTNERS LLP | 0.39% | 15,697 | 0.01% | $119,000 | |
| UBS Group AG | 0.19% | 7,857 | -72% | 0% | $59,320 |
| GROUP ONE TRADING LLC | 0.11% | 4,406 | -1.9% | 0% | $33,265 |
| Vanguard Global Advisers, LLC | 0.04% | 1,424 | 0% | 0% | $10,751 |
| Tower Research Capital LLC (TRC) | 0.03% | 1,113 | +235% | 0% | $8,403 |
| Axiom Investment Management LLC | 0.02% | 704 | 0% | 0% | $5,315 |
| MORGAN STANLEY | 0.01% | 487 | -0.2% | 0% | $3,677 |
| HARBOUR INVESTMENTS, INC. | 0% | 200 | 0% | 0% | $1,510 |
| NATIONAL BANK OF CANADA /FI/ | 0% | 193 | 0% | 0% | $1,448 |
| OSAIC HOLDINGS, INC. | 0% | 182 | +1.1% | 0% | $1,374 |
| SBI Securities Co., Ltd. | 0% | 152 | 0% | 0% | $1,148 |
| ROYAL BANK OF CANADA | 0% | 132 | 0% | 0% | $1,000 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 46 | 0% | 0% | $347 |
| JPMORGAN CHASE & CO | 0% | 12 | 0% | 0% | $88 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Latest
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 998,983 | $7,540,716 | -$251,686 | $7.55 | 26 |
| 2026 Q1 | 1,034,728 | $7,013,757 | -$1,066,549 | $6.78 | 31 |
| 2025 Q4 | 1,150,872 | $10,102,543 | -$49,623 | $8.78 | 32 |
| 2025 Q3 | 1,132,318 | $13,869,418 | +$1,072,340 | $12.25 | 30 |
| 2025 Q2 | 1,045,108 | $5,537,068 | +$5,536,814 | $5.30 | 27 |